Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Cancer Survivorship
Published in: Journal of Cancer Survivorship 2/2014

01-06-2014

Occurrence of comorbidities among African-American and Latina breast cancer survivors

Authors: Kimlin Ashing, Monica Rosales, Lily Lai, Arti Hurria

Published in: Journal of Cancer Survivorship | Issue 2/2014

Login to get access

Abstract

Background

The co-occurrence of multiple chronic conditions in cancer patients is common and can have negative impact on cancer and cancer survivorship outcomes. This study aimed to document comorbidity occurrence among African-American and Latina (English language preferred (ELP) and Spanish language preferred (SLP)) breast cancer survivors (BCS).

Methods

Eighty-eight African-American, 95 ELP Latina, and 137 SLP Latina BCS were recruited via case ascertainment from the California Cancer Registry and hospital registries. BCS completed a self-report questionnaire assessing demographic and cancer characteristics, and presence of comorbidities.

Results

Overall, 75 % of BCS reported at least one comorbidity with arthritis (37 %), high blood pressure (37 %), psychological difficulties (29 %), and diabetes (19 %) being most commonly endorsed. SLP Latinas were more likely to report diabetes (29 %), psychological difficulties (42 %), and >3 comorbidities (p < 0.05). Latina BCS were twice as likely to report osteoporosis and headaches compared to African-Americans; while one in two African-Americans reported hypertension and arthritis. Older age was correlated with arthritis, diabetes, glaucoma, high blood pressure, and osteoporosis.

Conclusions

Our findings suggest that investigating the occurrence of comorbidities across ethnic groups may shed some light in understanding cancer survivorship risk for poor health outcomes and health disparities. Having a better grasp of comorbid conditions may aid in more appropriate early assessment, better follow-up care, surveillance, and management of the cancer and the comorbid condition(s).

Implications for Cancer Survivors

Integrated control and management of comorbidities among cancer survivors has the potential to improve quality care for the whole person, and increase survival and decrease morbidity.
Literature
1.
Land LH et al. Comorbidity and survival after early breast cancer: a review. Crit Rev Oncol/Hematol. 2012;81:196–205.CrossRef
2.
Koroukian SM, Murray P, Madigan E. Comorbidity, disability, and geriatric syndromes in elderly cancer patients receiving home health care. JCO. 2006;24(15):2304–10.CrossRef
3.
4.
Smith AW et al. Cancer, comorbidities, and health related quality of life of older adults. Health Care Financ Rev. 2008;29(4):41–56.PubMedCentralPubMed
5.
Barone B et al. Postoperative mortality in cancer patients with preexisting diabetes: systematic review and meta-analysis. Diabetes Care. 2010;33(4):931–9.PubMedCentralCrossRefPubMed
6.
Kumar S, Hurria A. Impact of age, sex, and comorbidity on cancer therapy and disease progression. JCO. 2010;28(26):4086–93.CrossRef
7.
Yancik R et al. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 and older. JAMA. 2001;285(7):885–92.CrossRefPubMed
8.
Hershey DS et al. Perceived impact of cancer treatment on diabetes self-management. Diabetes Educ. 2012;38(6):779–90.CrossRefPubMed
9.
Berglund A et al. Impact of comorbidity on management and mortality in women diagnosed with breast cancer. Breast Cancer Res Treat. 2012;135:281–9.CrossRefPubMed
10.
Cronin-Fenton DP et al. Comorbidity and survival of Danish breast cancer patients from 1995-2005. Br J Cancer. 2007;96:1462–8.PubMedCentralPubMed
11.
Patnaik JL et al. The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst. 2011;103(14):1101–11.PubMedCentralCrossRefPubMed
12.
Peairs K et al. Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. JCO. 2011;29:40–6.CrossRef
13.
Polednak AP, Phillips CE. Obtaining data on comorbid diabetes among patients in a US population-based tumor registry. J Registry Manag. 2010;37(2):57–64.PubMed
14.
Smith MR. Treatment-related diabetes and cardiovascular disease in prostate cancer survivors. Ann Oncol. 2008;19(Supp 7):vii86–90.PubMedCentralPubMed
15.
16.
Braithwaite D et al. Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study. Cancer Epidemiol Biomark Prev. 2012;21(7):1115–25.CrossRef
17.
Tammemagi CM. Racial/ethnic disparities in breast and gynecologic cancer treatment and outcomes. Curr Opin Obstet Gynecol. 2007;19(1):31–6.CrossRefPubMed
18.
Tammemagi CM et al. Comorbidity and survival disparities among Black and White patients with breast cancer. JAMA. 2005;294(14):1765–72.CrossRefPubMed
19.
Louwman WJ et al. Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. Eur J Cancer. 2005;41(5):779–85.CrossRefPubMed
20.
Du XL, Fang S, Meyer T. Impact of treatment and socioeconomic status on racial disparities in survival among older women with breast cancer. Am J Clin Oncol. 2008;31(2):125–32.CrossRefPubMed
21.
Ashing-Giwa K, Ganz PA, Petersen L. Quality of life of African-American and White long-term breast cancer survivors. Cancer. 1999;85(2):418–26.CrossRefPubMed
22.
23.
24.
Fleming ST et al. A comprehensive prognostic index to predict survival based on multiple comorbidities: a focus on breast cancer. Med Care. 1999;37(6):601–14.CrossRefPubMed
25.
Ashing-Giwa K, Rosales M. A cross-cultural validation of patient-reported outcome measures: a study of breast cancers survivors. Qual Life Res. 2013;22:295–308.CrossRefPubMed
26.
Ashing-Giwa K et al. Depressive symptomatology among Latina breast cancer survivors. 2013;22:845–53.
27.
Janz NK et al. Racial/ethnic differences in quality of life after diagnosis of breast cancer. J Cancer Surviv. 2009;3:212–22.CrossRefPubMed
28.
Lopez ME et al. Ductal carcinoma in situ (DCIS): posttreatment follow-up care among Latina and non-Latina white women. J Caner Surviv. 2013;7(2):219–26.CrossRef
29.
Napoles AM et al. Interpersonal processes of care and patient satisfaction: do associations differ by race, ethnicity, and language? Health Serv Res. 2009;44(4):1326–44.PubMedCentralCrossRefPubMed
30.
Ashing K, Rosales M (2013) A telephonic-based trial to reduce depressive symptoms among Latina breast cancer survivors. Psychooncology (in press)
31.
Ashing-Giwa K et al. Breast cancer survivorship in a multiethnic sample: challenges in recruitment and measurement. Cancer. 2004;101(3):450–65.CrossRefPubMed
32.
Ashing-Giwa K et al. Examining predictive models of HRQOL in a population-based, multiethnic sample of women with breast carcinoma. Qual Life Res. 2007;16(3):413–28.CrossRefPubMed
33.
34.
Hurria A, Mohile S, Dale W. Research priorities in geriatric oncology: addressing the needs of an aging population. J Natl Compr Cancer Netw. 2012;10(2):286–8.
35.
Ring A, Sestak I, Baum M. Influence of comorbidities and age on risk of death without recurrence: a retrospective analysis of the Arimidex, Tamoxifen Alone or in combination trial. J Clin Oncol. 2011;29(32):4266–72.CrossRefPubMed
36.
Dwight-Johnson M, Ell K, Lee P-J. Can collaborative care address the needs of low-income Latinas with comorbid depression and cancer? Results from a randomized pilot study. Psychosom. 2005;46(3):224–32.CrossRef
37.
Buki LP et al. Latina breast cancer survivors’ lived experiences: diagnosis, treatment, and beyond. Cult Divers Ethn Minor Psychol. 2008;14(2):163–7.CrossRef
38.
Ell K et al. Improving treatment of depression among low-income patients with cancer: the design of the ADAPt-C study. Gen Hosp Psychiatry. 2007;29:223–31.PubMedCentralCrossRefPubMed
39.
Ell K et al. Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecologic cancer. J Clin Oncol. 2005;23(13):3052–60.PubMedCentralCrossRefPubMed
40.
Eversley R et al. Post-treatment symptoms among ethnic minority breast cancer survivors. Oncol Nurs Forum. 2005;32(2):250–5.CrossRefPubMed
41.
Eley JW et al. Racial differences in survival from breast cancer: results of the National Cancer Institute Black/White cancer survival study. JAMA. 1994;272:947–54.CrossRefPubMed
42.
Ashing-Giwa K, Rosales M. Recruitment and retention strategies of African American and Latina American breast cancer survivors in a longitudinal psycho-oncology study. Oncol Nurs Forum. 2012;39(5):E434–42.CrossRefPubMed
43.
Parsons HM et al. What happens to racial and ethnic minorities after cancer surgery at American College of Surgeons national surgical quality improvement program hospitals? J Am Coll Sug. 2012;214(4):539–49.CrossRef
44.
Weaver KE et al. Forgoing medical care because of cost: assessing disparities in health care access among cancer survivors living in the United States. Cancer. 2010;116(14):3493–504.PubMedCentralCrossRefPubMed
45.
Galvan N, Buki LP, Garces DM. Suddenly, a carriage appears: social support needs of Latina breast cancer survivors. J Psychosoc Oncol. 2009;27(3):361–82.CrossRefPubMed
Metadata
Title
Occurrence of comorbidities among African-American and Latina breast cancer survivors
Authors
Kimlin Ashing
Monica Rosales
Lily Lai
Arti Hurria
Publication date
01-06-2014
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 2/2014
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-014-0342-x

Other articles of this Issue 2/2014

Journal of Cancer Survivorship 2/2014 Go to the issue

OriginalPaper

Oncology providers’ evaluation of the use of an automatically generated cancer survivorship care plan: longitudinal results from the ROGY Care trial

OriginalPaper

Musculoskeletal changes after 1 year of exercise in older breast cancer survivors

OriginalPaper

The integration of cancer survivorship training in the curriculum of hematology/oncology fellows and radiation oncology residents

OriginalPaper

A controlled study of income development for breast cancer survivors in Norway

OriginalPaper

Evaluation of traditional and novel measures of cardiac function to detect anthracycline-induced cardiotoxicity in survivors of childhood cancer

OriginalPaper

Fostering coordinated survivorship care in breast cancer: who is lost to follow-up?
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits